MIC Capital Management UK LLP — 13F Holdings & Portfolio
CIK 1889830 · latest 13F-HR filed 2026-08-10
MIC Capital Management UK LLP manages $394.3M in 13F-reported U.S. long-equity assets across 16 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are HAYW (27.09%), RVMD (25.25%), RXRX (8.98%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions, exited 1, added to 4, and trimmed 5.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
25 BERKELEY SQUARE
LONDON, X0 W1J 6HN
$394.3M
Long-equity book
16
Distinct positions
2026-06-30
Filed 2026-08-10
+3 / −1 / ↑4 / ↓5
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- REVOLUTION MEDICINES INC$22.2M +28.7%
- HAYWARD HLDGS INC$18.9M +21.5%
- RECURSION PHARMACEUTICALS IN$5.8M +19.5%
- ROCKET LAB CORP$1.3M +58.3%
Top Trims
- KLARNA GROUP PLC-$18.3M -51.4%
- COUPANG INC-$2.1M -8.0%
- NEUMORA THERAPEUTICS INC.-$1.1M -12.8%
- LYELL IMMUNOPHARMA INC-$523.0K -30.0%
- ARCHER AVIATION INC-$308.0K -8.5%
New Positions
- ALIBABA GROUP HLDG LTD$14.4M
- CAPITAL ONE FINL CORP$9.6M
- BILLIONTOONE INC$586.9K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | HAYWARD HLDGS INC | HAYW | 421298100 | $106.8M | 27.09% | 6,171,527 | SH |
| 2 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $99.6M | 25.25% | 531,733 | SH |
| 3 | RECURSION PHARMACEUTICALS IN | RXRX | 75629V104 | $35.4M | 8.98% | 9,644,033 | SH |
| 4 | RESTAURANT BRANDS INTL INC | QSR | 76131D103 | $28.0M | 7.10% | 386,203 | SH |
| 5 | COUPANG INC | CPNG | 22266T109 | $24.5M | 6.22% | 1,412,946 | SH |
| 6 | GRAB HOLDINGS LIMITED | GRAB | G4124C109 | $18.9M | 4.78% | 5,000,000 | SH |
| 7 | META PLATFORMS INC | META | 30303M102 | $18.8M | 4.76% | 33,300 | SH |
| 8 | KLARNA GROUP PLC | KLAR | G5279N105 | $17.3M | 4.38% | 852,498 | SH |
| 9 | ALIBABA GROUP HLDG LTD | BABA | 01609W102 | $14.4M | 3.65% | 150,000 | SH |
| 10 | CAPITAL ONE FINL CORP | COF | 14040H105 | $9.6M | 2.44% | 48,011 | SH |
| 11 | NEUMORA THERAPEUTICS INC. | NMRA | 640979100 | $7.6M | 1.92% | 4,460,700 | SH |
| 12 | MONDAY COM LTD | MNDY | M7S64H106 | $4.8M | 1.21% | 66,000 | SH |
| 13 | ROCKET LAB CORP | RKLB | 773121108 | $3.6M | 0.92% | 35,628 | SH |
| 14 | ARCHER AVIATION INC | ACHR | 03945R102 | $3.3M | 0.84% | 700,000 | SH |
| 15 | LYELL IMMUNOPHARMA INC | LYEL | 55083R203 | $1.2M | 0.31% | 87,028 | SH |
| 16 | BILLIONTOONE INC | BLLN | 090168105 | $586.9K | 0.15% | 4,892 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-10 | $394.3M | 16 | 0001889830-26-000003 |
| 2026-03-31 | 2026-05-13 | $352.5M | 18 | 0001889830-26-000002 |
| 2025-12-31 | 2026-02-17 | $441.3M | 13 | 0001889830-26-000001 |
| 2025-09-30 | 2025-11-14 | $500.3M | 13 | 0001889830-25-000003 |